PSI Webinar Patient Engagement in Clinical Trials Date for Webinar: Tuesday 13th June 2:30-3:30pm UK time
Patients have long been an important part of clinical drug development – without them, there would be no new medicines. Recently, there has been a fundamental shift in their involvement in the drug development process. Today, patients are highly active in engaging in discussions about their disease, what they look for in new treatments, and how clinical trials are designed and conducted.
Following on from the successful and thought-provoking presentation at last year’s PSI conference by Paul Wicks from PatientsLikeMe, this webinar will continue to explore the ways in which patients are influencing the design of new clinical trials. We have two speakers who bring different experience and perspectives on this subject:
Dr Cathy Emmas, Partnership Director, Patient Centricity, AstraZeneca Title: Patient-centric medicines development – the value of online health communities
Abstract: How AstraZeneca’s collaboration with the PatientsLikeMe is accelerating our ability to generate the timely and relevant patient insight that enables informed decision making within our R&D programs. What patient-generated health data tells us about symptoms and outcomes that matter to patients. Optimisation of clinical trials from the patient perspective.
Biography: Cathy is the Partnership Director in AstraZeneca’s global Patient Centricity team where she leads a 5 year strategic collaboration with the PatientsLikeMe online health network. This alliance was established to accelerate our ability to generate the right patient insight that enables informed decision making within our R&D programs and shape healthcare delivery. In the first two years the collaboration has linked the experiences of over 70,000 patients into our lifecycle teams and patient preferences have helped shape 12 clinical studies across 7 diseases.
Professor Sue Pavitt, Dental Translational and Clinical Research Unit, University of Leeds
Title: Achieving Effective Patient Public Involvement in Clinical Trials: “No research about us without us”
Abstract: Patient public involvement in medicine research and development has gained significant momentum. Adopting a patient-centric approach in clinical trials and research is important to ensure new treatments embrace what is important to patients. Achieving effective Patient Public Involvement & Engagement (PPIE ) partnerships enhances the relevance of clinical research and improved likelihood of delivering patient benefits. PPI also contributes to the operational efficiency and success in clinical trial design, ethical approval, conduct and dissemination reach; collectively building cross sector communication and partnerships may enhance market head room long term. I will provide a background to patient public involvement and establishing effective partnerships and illustrative case examples that support patient awareness of their treatment options and healthcare choices. I will introduce EUPATI and its role in meeting the educational needs to deliver patient centric medicine R&D and facilitate partnerships between patients-academia and industry in clinical research. We are in an era of a paradigm shift in patient-centric clinical trials, by strategically bringing the patient lived experience to the forefront has the potential to change fundamentally how health care is practiced.
Biography: Sue Pavitt - Prof in Translational & Applied Health Research, University of Leeds. Her PhD was in Human Cancer Genetics and she had a high profile career working with Prof Sir Walter Bodmer mapping the first colorectal cancer gene. She worked on the Human Genome Project at UCL, Oxford and UCSF, USA. In 1998 she was appointed as the Founding Director of TayRen – the premier Scottish multidisciplinary Primary Care Research network and the academic focus of her career changed to applied health research. She became the Divisional Director at the Clinical Trials Research Unit, Leeds and has since gone on to Head the Division for Applied Health and Clinical Translation and is Director of the Dental Translation and Clinical Research Unit. She is a Specialty lead for the Oral & Dental Health National Institute of Health Research (NIHR) Clinical Research Network. She is Chair of Multiple Sclerosis Clinical Trials Network. She is a Board Member of the MRC-NIHR Efficacy & Mechanistic Evaluation and in this capacity evaluated clinical trial design. Her research portfolio spans several disease areas and is characterized by forging effective, multi-disciplinary research partnerships between clinicians, academics, sometimes industry and always patients; developing methodological sound projects that are patient-centric with research questions tailored to clinical priorities to maximize impact and patient benefit.
Sue is passionate about patient involvement in research with >30 years’ experience. She is the Academic Lead for EUPATI-UK – European Patient Advocacy for Therapeutic Innovation- a pan-European Innovative Medicines Initiative, led by the European Patients' Forum, in partnership with patient organizations, universities, not-for-profit organizations and pharmaceutical companies. EUPATI’s goal is to increase capacities and capabilities of well-informed patients to be effective advocates/advisors in medicines research.
Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
Joint PSI/EFSPI Pre-Clinical SIG Webinar: Virtual Control Groups in Toxicity Studies
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
Joint PSI/EFSPI Data Science SIG Webinar: Developing Digital Measures (Digital Biomarkers) in Drug Development – insights from Mobilise D consortium
We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
PSI Webinar: Development of Gene Therapies: Strategic, Scientific, Regulatory and Access Considerations
This webinar will cover the history of cell/gene therapy, major regulatory advances, the role of quantitative scientists in drug development of these novel therapeutics, and discuss opportunities for innovation and product advancement.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
PSI Introduction to Industry Training (ITIT) Course - 2024/2025
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
Statisticians in the Pharmaceutical Industry Executive Office: c/o MCI UK Ltd | Unit 24/22 South | Building 4000 | Langstone Park| Langstone Road | Havant | PO9 1SA | UK